[
    "{\"step_by_step_thinking\": \"Tocilizumab is a biological disease-modifying antirheumatic drug (bDMARD), not a conventional synthetic disease-modifying antirheumatic drug (csDMARD). This is evident from the information provided in the documents, which consistently refer to tocilizumab as a bDMARD.\", \"answer_choice\": \"B\"}"
]